Introduction
============

Prostaglandins (PGs) and other eicosanoids are oxygenated metabolites of three C20 polyunsaturated fatty acids (PUFAs), 20:3n-6, 20:4n-6, and 20:5n-3. Of the three, conversion of 20:4n-6, arachidonic acid (AA), into eicosanoids is the most widely considered pathway. Although 20:5n-3, eicosapentaenoic acid has been detected in terrestrial animals, it occurs in higher proportions of total phospholipid fatty acids in marine and aquatic invertebrates and vertebrates. In this essay we focus on AA metabolism, which is converted into three broad groups of eicosanoids, PGs, epoxyeicosatrienoic acids and a collection of lipoxygenase (LOX) products, such as hydroxyeicosatrienoic acids and leukotrienes. All three groups of eicosanoids occur in insects.

Eicosanoids are generally biosynthesized within cells. They are exported into circulating blood or, in insects, hemolymph, where they may act in autocrine or paracrine mechanisms through cell surface receptors. Here, we review the three major steps of PG biosynthesis in insects. The first step is the release of PUFAs from membrane phospholipids (PLs) by phospholipase A~2~ (PLA~2~) ([Figure 1](#F1){ref-type="fig"}). The second step marks a major departure from the biomedical background, because genes encoding the cyclooxygenase (COX) responsible for converting C20 PUFAs into PGs do not occur in the known insect genomes. In an alternative insect mechanism, a peroxidase (peroxinectin: Pxt) catalyzes the formation of PGH~2~, with the five-membered ring structure that characterizes PGs ([@B67]). The third step depends on cell-specific enzymes that convert PGH~2~ into any of several PGs, PGE~2~ ([@B4]). Here, we treat new discoveries in insect PG biosynthesis.

![A model for eicosanoid biosynthesis in insects. PLA~2~ activated by calcium or mitogen-activating protein kinase (MAPK) catalyzes the hydrolysis of linoleic acid (LA), which is extended in chain length to C20 fatty acid by a specific elongase (ELO). The C20 precursor is oxidized by desaturases (DES) to produce arachidonic acid (AA; [@B108]), which is oxygenated by epoxidase (EPX) to produce epoxyeicosatrienoic acid (EET), by lipoxygenase (LOX) to produce leukotriene (LT) or by a specific peroxinectin (Pxt) to produce prostaglandin H~2~ (PGH~2~). PGH~2~ is then isomerized by PGE~2~ synthase-2 (PGES-2) to PGE~2~.](fphys-09-01927-g001){#F1}

[@B105], a monograph covering all invertebrates, and [@B106] provide detailed chemical structures and outline eicosanoid biosynthetic pathways. We do not repeat the chemical structures in detail here, with the exception of structures of three major eicosanoid groups to facilitate reading without looking up the structures. The purpose of this review is to integrate the new information into a slightly clearer picture of eicosanoid biosynthesis with current transcriptome-based functional studies. In addition, eicosanoid actions in insects are explained in different physiological processes of reproduction, metabolism, and immunity.

Discovery and Expansion of Known Insect PLA~2~*s*
=================================================

PLA~2~ was initially discovered from snake venom components ([@B21]) and in mammalian systems ([@B47]). Later, as non-disulfide bond-containing PLA~2~s were recognized, it became necessary to classify PLA~2~s into groups ([@B23]). At least 16 PLA~2~ groups are now recognized, including five major types: secretory PLA~2~s (sPLA~2~s: Groups I--III, V, IX, X, XI, XII, XIII, XIV, and XV), calcium-dependent intracellular PLA~2~ (cPLA~2~: Group IV), calcium-independent intracellular PLA~2~ (iPLA~2~: Group VI), Lipoprotein-associated PLA~2~ (LpPLA~2~: Groups VII and VIII), and adipose phospholipase A~2~ (AdPLA~2~: Group XVI) ([@B119]). sPLA~2~ and LpPLA~2~ are secretory proteins that act on extracellular membrane lipids, while cPLA~2~ and iPLA~2~ catalyze hydrolysis of fatty acids from intracellular PLs. However, the localization of LpPLA~2~ and AdPLA~2~ remains unclear.

PLA~2~ actions include digestion of dietary lipids, remodeling cellular membranes, signal transduction, host immune defenses, and production of various lipid mediators or inactivation of a lipid mediator. There also are non-catalytic PLA~2~s that act as ligands by binding to receptors or binding proteins ([@B115]). Here, we briefly introduce general characters of five major types of PLA~2~s before discussing various insect PLA~2~s.

Classification of PLA~2~s
-------------------------

sPLA~2~s are small enzymes (14--18 kDa) with calcium activation ([@B87]). They contain highly conserved amino acid residues and sequences. All organisms express sPLA~2~, including viruses ([@B30]), bacteria ([@B86]), plants ([@B101]), and invertebrates ([@B46]), where they exert various actions.

iPLA~2,~ PNPLA9, or iPLA~2~β, is a calcium-independent PLA~2~ that acts in membrane remodeling ([@B2]). The longest variant of iPLA~2~ has a catalytic dyad of Ser/Asp and is comprised of seven ankyrin repeats, a linker region, and a patatin-like α/β hydrolase catalytic domain ([@B49]).

cPLA~2~ is classified into Group IVA of the PLA~2~ superfamily ([@B16]). It is an 85 kDa protein and regulated by intracellular calcium. This enzyme is widely distributed in cells throughout most types of human tissues and consists of two functional domains C2 and α/β hydrolase. Calcium-binding to the C2 domain causes translocation of the protein to a PL membrane ([@B15]). cPLA~2~ catalyzes AA release from various PLs and has lysophospholipase and *trans*-acylase activities ([@B79]).

Platelet-activating factor (PAF) is a potent PL mediator that plays a major role in clotting and inflammatory pathways ([@B74]). LpPLA~2~ catalyzes the hydrolysis of the *sn-2* fatty acid in PAF or other lipid substrate and is thus called PAF acetyl hydrolase (PAF-AH; [@B112]; [@B100]).

Group XVI PLA~2~ is AdPLA~2~ abundant in adipose tissue ([@B25]) and acts in lipolysis via the production of eicosanoid mediators ([@B40]).

Biochemical and Molecular Characters of Insect PLA~2~s
------------------------------------------------------

Like vertebrates, PLA~2~ activity acts in lipid digestion, metabolism, secretion, reproduction, and immunity in insects ([@B102]). Three types of PLA~2~s are detected in insects ([Table 1](#T1){ref-type="table"}). In lipid digestion, PLA~2~ performs two crucial roles by direct hydrolysis of dietary PLs at the *sn-2* position to generate nutritionally essential PUFAs and by providing lysophospholipids as insect "bile salts" that solubilize dietary neutral lipids for digestion by other lipases ([@B103]). The predatory tiger beetle, *Cicindella circumpicta* expresses a midgut calcium-dependent PLA~2~ activity ([@B118]). Protein fractionation indicated that the enzyme activity was detected in low molecular weight range (about 22 kDa), suggesting a sPLA~2~. *Manduca sexta* secretes PLA~2~ activity from midgut *in vitro* cultures and catalyzes AA release from PL ([@B77]; [@B78]). Larvae of the mosquitoes *Aedes aegypti*, *A. albopictus*, and *Culex quinquefasciatus* express midgut PLA~2~ activity ([@B63]; [@B1]). The peaks of the enzyme activity followed feeding cycles of the mosquito larvae. Similar iPLA~2~-like activity comes from salivary gland of *M. sexta* ([@B117]). Burying beetles, *Nicrophorus marginatus*, inter small mammals as larval food and express a salivary PLA~2~ to protect the bodies from decomposition during larval development ([@B76]). [@B81] characterized a gene encoding a *D. melanogaster* PLA~2~, which increased interest in insect PLA~2~s.

###### 

Phospholipase A~2~ activities in insects and their predicted PLA~2~ types.

  Types     Species                     Tissues               Enzyme activities^1^                       Reference
  --------- --------------------------- --------------------- ------------------------------------------ -----------
  sPLA~2~   *Cicindella circumpicta*    Midgut lumen          • Calcium dependency                       [@B118]
                                                              • AA release from PL                       
                                                              • Sensitivity to OOPC inhibitor            
                                                              • \<22 kDa size                            
            *Nicrophorus marginatus*    Oral secretion        • Calcium dependency                       [@B76]
                                                              • AA release from PL                       
            *Cochliomyia hominivorax*   Midgut                • Calcium dependency                       [@B62]
                                                              • AA release from PL                       
                                                              • Sensitivity to OOPC inhibitor            
            *Manduca sexta*             Midgut secretion      •*In vitro* secretion of PLA~2~ activity   [@B78]
                                                              • AA release from PL                       
            *Drosophila melanogaster*   Recombinant protein   • Calcium dependency                       [@B81]
                                                              • AA release from PL                       
                                                              • 138 amino acids                          
            *Rhodnius prolixus*         Plasma                • Calcium dependency                       [@B31]
                                                              •*sn-2* ester bond hydrolysis              
            *Tribolium castaneum*       Recombinant protein   • BPB sensitivity                          [@B95]
                                                              •*sn-2* ester bond hydrolysis              
                                                              • 173--261 amino acids                     
            *Spodoptera exigua*         Plasma                • BPB sensitivity                          [@B120]
                                                              •*sn-2* ester bond hydrolysis              
  iPLA~2~   *Aedes aegypti*             Midgut                • Calcium independency                     [@B63]
                                                              • AA release from PL                       
                                                              • Insensitivity to OOPC inhibitor          
            *Manduca sexta*             Midgut                • Calcium independency                     [@B77]
                                                              • AA release from PL                       
                                                              • Insensitivity to OOPC inhibitor          
                                        Salivary gland        • Calcium independency                     [@B117]
                                                              • AA release from PL                       
                                                              • Sensitivity to OOPC inhibitor            
            *Rhodnius prolixus*         Hemocytes             • Calcium independency                     [@B31]
                                                              •*sn-2* ester bond hydrolysis              
            *Spodoptera exigua*         All tissues           • BEL sensitivity                          [@B83]
                                                              •*sn-2* ester bond hydrolysis              
  cPLA~2~   *Rhodnius prolixus*         Hemocytes             • Calcium dependency                       [@B31]
                                                              •*sn-2* ester bond hydrolysis              
            *Spodoptera exigua*         All tissues           • MAFP sensitivity                         [@B83]
                                                              •*sn-2* ester bond hydrolysis              

1

PL, for phospholipid; AA, for arachidonic acid; BPB, for promophenacyl promide; BEL, for bromoenol lactone; MAFP, for methyl arachidonyl fluorophosphates; OOPC, for oleyloxyethylphosphorylcholine

.

Recent work by [@B83] using specific PLA~2~ inhibitors supports the concept of multiple PLA~2~ activities in several tissues of larval *Spodoptera exigua*. [@B120] recorded cellular PLA~2~ activity in *S. exigua* plasma which is enhanced in response to immune challenge.

All venomous sPLA~2~s are clustered into the Group III in PLA~2~s. Similar sPLA~2~s were predicted from *Tribolium castaneum* genome ([@B95]). Five sPLA~2~s encode 173--261 amino acids, in which eight cysteines are conserved. We infer the enzyme is stabilized by formation of four disulfide bonds. All five sPLA~2~s are expressed in different developmental stages of *T. castaneum*. Among them, four PLA~2~s are associated with cellular immune functions. Two sPLA~2~ genes are encoded and expressed in a hemipteran insect, *R. prolixus* ([@B22]). These are named as Rhopr-PLA2III and Rhopr-PLA2XII because they have Group III and XII-specific active site sequences of "C-C-R-T-H-D-L-C" and "C-C-N-E-H-D-I-C," respectively. Both sPLA~2~ genes are expressed in most nymphal tissues (especially salivary gland) of *R. prolixus*, in which Rhopr-PLA2XII was more highly expressed than Rhopr-PLA2III.

The first lepidopteran non-venom sPLA~2~ was identified from *S. exigua* ([@B120]), which encodes 194 amino acids containing three domains, a signal peptide, a calcium-binding domain, and a catalytic site. This enzyme clusters with other Group III sPLA~2~s. Though all insect sPLA~2~s are clustered in Group III, venomous and non-venomous sPLA~2~s are distinct in amino acid sequences ([Figure 2](#F2){ref-type="fig"}). Venomous sPLA~2~s have more cysteine residues than their non-venomous counterparts, which they may need more stable structures to sustain enzyme activity in external environments ([@B44]).

![Phylogenetic analysis of venomous and non-venomous sPLA~2~s. The tree was constructed with Neighbor-joining method using MEGA6.0. Bootstrapping values on branches were obtained with 1,000 repetitions. Amino acid sequences were retrieved from GenBank. Accession numbers are PBC33208.1 for *Apis cerana cerana* (Acer), XP_006621273.1 for *A. dorsata* (Ador), XP_003694784.1 for *A. florea* (Aflo), KYM84159.1 for *Atta colombica* (Acol), XP_003491197.1 for *Bombus impatiens* (Bimp), XP_003400956.1 for *B. terrestris* (Bter), XP_017884585.1 for *Ceratina calcarata* (Ccal), KYM98685.1 for *Cyphomyrmex costatus* (Ccos), KOC68767.1 for *Habropoda laboriosa* (Hlab), XP_003699810.1 for *Megachile rotundata* (Mrot), KOX79218.1 for *Melipona quadrifasciata* (Mqua), JAC85837.1 for *Panstrongylus megistus* (Pmeg), XP_015172342.1 for *Polistes dominula* (Pdom), XP_014602740.1 for *P. canadensis* (Pcan), XP_011150082.1 for *Harpegnathos saltator* (Hsal), XP_008560296.1 for *Microplitis demolitor* (Mdem), NP_001014501.1 for *Drosophila melanogaster* (Dmel), XP_021189466.1 for *Helicoverpa armigera* (Harm), MH061374 for *Spodoptera exigua* (Sexi), JAI14574.1 for *Tabanus bromius* (Tbro), KYQ53077.1 for *Trachymyrmex zeteki* (Tzet), JAS01512.1 for *Triatoma infestans* (Tinf), NP_001139389.1 for *Tribolium castaneum* A (TcasA), NP_001139390.1 for TcasB, NP_001139461.1 for TcasC, NP_001139342.1 for TcasD, XP_966735.2 for TcasE, and XP_021915493.1 for *Zootermopsis nevadensis* (Znev).](fphys-09-01927-g002){#F2}

As seen in the *Tribolium* and *Spodoptera* systems, sPLA~2~s are likely to mediate immune responses via AA release because RNA interference (RNAi)-treated larvae exhibited significant immunosuppression and AA treatments rescued the immune responses ([@B95]; [@B120]). An additional sPLA~2~ immune function may be its direct antibacterial activity in hemolymph. In mammals, Group IIa sPLA~2~ is one of the most effective antibacterial agents by hydrolyzing the bacterial membrane PLs ([@B122]).

[@B72] reported an insect iPLA~2~ in *S. exigua* (SeiPLA~2~A). SeiPLA~2~A encodes a protein with 816 amino acids with a predicted molecular weight of 90.5 kDa. SeiPLA~2~A clusters with Group VIA, which is characterized by multiple ankyrin repeats in the N-terminal region with a consensus lipase motif ("GTSTG") in the C-terminal region ([@B121]). SeiPLA~2~A was localized in cytoplasm by an immunofluorescence assay. dsSeiPLA~2~A treatments suppressed gene expression and enzyme activity and led to two pathological phenotypes, loss of cellular immune response and extended larval-to-pupal development. Another iPLA~2~, denoted SeiPLA~2~B, was identified in *S. exigua* ([@B82]). This enzyme differs from SeiPLA~2~A in several fundamental ways. SeiPLA~2~B is a small iPLA~2~, encoding 336 amino acids with a predicted size of about 36.6 kDa. It lacks ankyrin repeats in the N-terminal region. SeiPLA~2~B clusters with Group VIF. Both SeiPLA~2~A and SeiPLA~2~B are expressed in all developmental stages. The insect iPLA~2~s are separated into ankyrin and non-ankyrin types ([Figure 3](#F3){ref-type="fig"}). An iPLA~2~ gene was also identified from another lepidopteran insect, *Bombyx mori* ([@B64]) and it is rich in glycine-histidine repeats. This iPLA~2~ is highly expressed in fat body and RNAi treatments led to severe abnormal development and mortality.

![Two groups of insect iPLA~2~s. Phylogenetic analysis was performed by the Neighbor-joining method using the software package MEGA 6.0. Bootstrap values (expressed as percentage of 1,000 replications) are shown next to the branches. Amino acid sequences were retrieved from GenBank with accession numbers: XP_011063787.1 for *Acromyrmex echinatior* (Aech), XP_006565723 for *Apis mellifera* (Amel), XP_001944054.1 for *Acyrthosiphon pisum* (Apis), XP_004931589.1 for *Bombyx mori* (Bmor), JAI19791.1 for *Bactrocera latifrons* (Blat), XP_014090410.1 for *Bactrocera oleae* (Bole), XP_003492592.1 for *Bombus impatiens* (Bimp), XP_011261757.1 for *Camponotus floridanus* (Cflo), XP_015115454.1 for *Diachasma alloeum* (Dall), XP_015122829.1 for *Diachasma alloeum* (Dallo), XP_014488689.1 for *Dinoponera quadriceps* (Dqua), XP_015368613.1 for *Diuraphis noxia* (Dnox), JAG76826.1 for *Fopius arisanus* (Fari), XP_014284806.1 for *Halyomorpha halys* (Hhal), XP_011144133 for *Harpegnathos saltator* (Hsal), AGG55019.1 for *Heliothis subflexa* (Hsub), AGG55005.1 for *Heliothis virescens* (Hvir), JAQ13976.1 for *Lygus hesperus* (Lhes), XP_003702751.1 for *Megachile rotundata* (Mrod), XP_008559240.1 for *Microplitis demolitor* (Mdem), XP_012538958.1 for *Monomorium pharaonis* (Mpha), XP_015521797.1 for *Neodiprion lecontei* (Nlec), XP_022912622.1 for *Onthophagus taurus* (Otau), XP_011347626.1 for *Ooceraea biroi* (Obir), XP_011340273.1 for *Ooceraea biroi* (Obiro), KOB75232.1 for *Operophtera brumata* (Obru), XP_013147925.1 for *Papilio polytes* (Ppol), XP_014361526.1 for *Papilio machaon* (Pmac), XP_002432031.1 for *Pediculus humanus corporis* (Phum), XP_011641703.1 for *Pogonomyrmex barbatus* (Pbar), XP_013165315.1 for *Papilio xuthus* (Pxut), XP_011550190.1 for *Plutella xylostella* (Pxyl), JAP82800.1 for *Rhipicephalus appendiculatus* (Rapp), XP_011170109.1 for *Solenopsis invicta* (Sinv), XP_018367102.1 for *Trachymyrmex cornetzi* (Tcor), XP_018301493.1 for *Trachymyrmex zeteki* (Tzet), XP_971204.1 for *Tribolium castaneum* (Tcas), XP_011693263.1 for *Wasmannia auropunctata* (Waur), AIN39484.1 for *Spodoptera exigua* A (SexA), and AQW44791.1 for *Spodoptera exigua* B (SexB).](fphys-09-01927-g003){#F3}

A molecular signature of vertebrate cPLA~2~ is the C2 domain, responsible for calcium-dependent translocation of the enzyme to membranes ([@B61]), which has not been recorded in insects. Variation of PLA~2~ types were analyzed in *S. exigua* in different developmental stages and tissues ([@B83]). All developmental stages have significant PLA~2~ activities. Among larval tissues, hemocytes had higher PLA~2~ activities than fat body, gut, or epidermis. Different tissues of fifth instar larvae exhibited variation in susceptibility to inhibitors, with epidermal tissue sensitive to cPLA~2~ inhibitor alone while other tissues are sensitive to all three inhibitor types. The variation of PLA~2~ types in a one species may offer differential mediation of immune functionalities via eicosanoid signaling. In *S. exigua* plasmatocytes, intracellular calcium ion is required for cell spreading, which is inhibited by a calcium chelator ([@B99]). In *M. sexta*, PLA~2~ activity in the cytosolic fraction was significantly inhibited by treatment with a cPLA~2~-specific inhibitor, methyl arachidonyl fluorophosphate ([@B68]). We infer insect cPLA~2~s occur in a novel molecular form.

Some Entomopathogens Target Insect PLA~2~ for Pathogenicity
-----------------------------------------------------------

Eicosanoids transmit non-self recognition to hemocytes and fat body for systemic immune responses ([@B106]). Blocking eicosanoid biosynthesis would be a highly effective immunosuppressive strategy in entomopathogen-insect interactions ([@B44]). This pathogenic strategy is used by some entomopathogens. One example is *Trypanosoma rangeli*, which is a mammalian parasite transmitted by the bite of triatomid bugs, *Rhodnius*, and *Triatoma* ([@B35]). The parasites develop within the insect hemolymph and then make their way to the salivary glands for the transmission. In *R. prolixus*, *T. rangeli* suppresses hemocyte phagocytosis by suppressing PLA~2~ activity to inhibit eicosanoid biosynthesis ([@B31]). Indeed, the addition of AA prevented the parasite infection. Another example is reported in two genera of entomopathogenic bacteria, *Xenorhabdus* and *Photorhabdus* ([@B45]). These bacteria are symbionts of entomopathogenic nematodes (EPNs) in the Steinernematidae and Heterorhabditidae ([@B33]; [@B90]). After infective juvenile (IJ) nematodes enter host insects, they release symbiotic bacteria into host hemocoel ([@B32]), which rapidly induces immunosuppression in their hosts ([@B69], [@B70]). Subsequently, the nematodes develop and reproduce in the insect cadaver ([@B5]). To induce the host immunosuppression, *Xenorhabdus* and *Photorhabdus* inhibit PLA~2~ activity to block eicosanoid biosynthesiss ([@B45]). In pioneering research with *X. nematophila* and their symbiont EPN, *S. carpocapsae*, [@B69] injected the bacteria into *S. exigua*. They explored the hypothesis that bacterial factors act to suppress insect immunity by inhibiting eicosanoid biosynthesis. In their first test of the hypothesis, they injected AA into bacterial-infected larvae, which rescued the insect immune responses. They also injected the PLA~2~ inhibitor, dexamethasone (DEX) which substantially increased the bacterial virulence. This led to another hypothesis that bacterial secretions inhibit PLA~2~ activity and all downstream biosynthesis of eicosanoids. The authors used a quantifiable, specific immune function, hemocyte nodule formation (nodulation), to monitor the change in immune response after bacterial challenge. Injection of heat-killed *X. nematophila* induced about 57 nodules per larva, compared to the same treatment with live *X. nematophila*, with less than 10 nodules, indicating substantial reduction in the cellular immunity. Injecting AA increased nodulation in the larvae treated with live *X. nematophila*. Therefore, the authors inferred that two genera of entomopathogenic bacteria, *Xenorhabdus* and *Photorhabdus* inhibit PLA~2~ to induce host immunosuppression ([@B45]). Several commercial sPLA~2~ preparations from porcine pancreas, honey bee venom, and snake (*Naja mossambica*) venom were strongly inhibited by an organic extract of the *Xenorhabdus* culture broth ([@B71]). To test the bacterial extract on insect sPLA~2~ activity, an immune-associated sPLA~2~ from *T. castaneum* was overexpressed, and it was inhibited by the bacterial extract ([@B93]). We propose the principle that host nematodes and their symbiotic bacteria suppress insect host immune responses by inhibiting PLA~2~ activity to optimize their pathogenicity. [@B3] supports the idea with their report of a functional correlation between the bacterial virulence and its inhibitory intensity against host PLA~2~ activity.

Production of multiple PLA~2~ inhibitors by the bacteria is more nuanced that first thought because the inhibitors are produced in a sequential pattern during bacterial growth and they exert additional inhibitory activities against different immune responses ([@B29]). They identified seven bacterial secondary metabolites, in which benzylideneacetone and a dipeptide (pro-tyr) are the most potent to inhibit PLA~2~. Though other five bacterial compounds can inhibit PLA~2~, they exhibit high inhibitory activities against PO enzyme activity or hemolytic activity to lead to insect immunosuppression ([@B88]). Because these bacterial secondary metabolites are produced at different bacterial growth phases, we infer that *X. nematophila* sequentially produces them to sequentially and cooperatively inhibit different steps of insect immune responses, including PLA~2~ activity.

The entomopathogens also inhibit the direct PLA~2~-mediated antibacterial activity. In *S. exigua*, the hemolymph from naïve larvae exhibits high sPLA~2~ activity, which is further increased in response to bacterial immune challenge ([@B120]). Thus, we propose that *Xenorhabdus* and *Photorhabdus* bacteria released from host nematodes inhibit sPLA~2~ in the hemolymph to protect themselves from antibacterial enzyme activity and suppress insect immunity.

Biological Significance of Eicosanoids in Insects
=================================================

Eicosanoid and Insect Reproduction
----------------------------------

[@B53] injected 50 mg PGE~2~ into virgin female crickets, *Teleogryllus commodus*, and observed more than fourfold increase in oviposition behavior compared to saline-injected controls. He concluded that PGE~2~ is an oviposition stimulant, noting that the PG action site was unknown, possibly via direct action on ovaries or muscles involved in oviposition. We will see that neither was correct.

Loher and his colleagues investigated the point in more detail ([@B54]). They found about 500 pg PGE~2~ in spermathecae from mated, but not virgin females. Spermathecae contained far less PGE~2~, about 20 pg/spermatophore. They found that spermatophores and spermathecae from mated, but not virgin, females biosynthesized about 25--35 pmol PGE~2~/h/gland and smaller amounts of PGF~2α~. This became the basis of the "enzyme transfer" model, in which a PG biosynthesis activity is transferred to females via spermatophores. Within spermathecae, the transferred enzyme activity converts AA into PGE~2~, which is released into hemolymph circulation. The precise target of the PGE~2~ remains unknown, although the PGs may interact with a specific receptor located in the terminal abdominal ganglion, the site of the egg-laying behavioral program.

[@B48] reported the transfer of PG synthase activity during mating in *Locusta migratoria*. Mating led to a fourfold increase in PG biosynthesis, compared to virgins, in spermathecal preparations. Mating, but not PG treatments, led to substantial increases in egg laying. Similarly, [@B13] recorded the presence of AA and PG biosynthesis in spermatophores and testes of the hematophagous kissing bug, *Triatoma infestans*. The PG synthase activity is transferred to females during mating because there was PGE~2~ synthase activity in spermatophores and a low enzyme activity in spermathecae from mated, but not virgin, bugs. The authors speculated the PGs release egg-laying behavior in *T. infestans*.

PGs release egg-laying behavior in an unknown number of insect species, certainly not all and not even all cricket species. [@B50] reported that treating short-tailed crickets, *Anurogryllus muticus* with PGs did not influence oviposition behavior. Nonetheless, releasing egg-laying behavior is one of several PG actions in insect reproduction.

[@B56] investigated the idea that PG signaling acts in follicle development in silk moth, *B. mori*. Incubating follicular epithelial cells in the presence of PG biosynthesis inhibitors, aspirin and, separately, indomethacin, blocked transition from follicle development to choriogenesis. They suggested the PGs act in follicle homeostatic physiology, rather than signaling a more specific developmental step.

[@B113] used *in vitro* follicle cultures prepared from *D. melanogaster* to show that stage 10B egg chamber maturation is inhibited in a dose-related manner by the presence of aspirin or the selective COX-2 inhibitor, NS-398. Treating follicles with PGH~2~ partially rescued development. Noting that mammalian COXs may have evolved from heme-dependent peroxidases, the authors identified a *Drosophila* peroxidase, Pxt, which produces PGs in a COX-like manner. They also advanced thinking about PG actions beyond general homeostasis to identification of a specific PG action in the actin cytoskeleton within ovarian follicles ([@B98]).

Tootle and her colleagues found more than 150 genes are expressed in specific stages during the final day of follicle development ([@B114]), including known and new genes encoding egg shell proteins. Mutations in the *Drosophila Pxt* and RNAi treatments lead to mis-timed appearance of transcripts encoding egg shell proteins and defective egg shells.

The biological significance of the work on *Drosophila* follicle development lies in *Drosophila* as a model of insect and mammalian molecular processes, which teaches that these molecular processes are very basic biological events. They likely occur in most, if not all, animals. Here, we pose this as a recurrent theme, indicating that some PG actions recorded in insects are fundamental actions in virtually all insects, and likely arthropod, species.

PG Actions in Cockroach Fat Body
--------------------------------

Steele and his colleagues investigated the biology of hypertrehalocemic hormones (HTH-I and -II). Their model was composed of disaggregated trophocytes prepared by treating fat bodies isolated from the cockroach, *Periplaneta americana*, with collagenase. HTH treatments led to increased concentrations of free fatty acids in the trophocytes. Treatments with the LOX inhibitor nordihydroguairaretic acid (NDGA) and COX-inhibitor (indomethacin: INDO) inhibited the release of free fatty acids. The authors inferred the free fatty acids, or their metabolites, act in synthesis and release of trehalose from trophocytes ([@B9]). They later suggested the increased free fatty acid concentrations are regulated by PLA~2~ and COX activities ([@B7]). This is the first recognition that PG and other eicosanoid signaling mediate HTH actions. In direct testing of the idea that PGs act in trehalose synthesis in the isolated trophocytes, they treated separate preparations with HTH, 18:0, 18-1n-9, 18:2n-6, or AA, all of which created similar increases in trehalose synthesis. They also reported that HTH-I treatments led to increased biosynthesis of 20:3n-6 and 20:4n-6, which was blocked by INDO treatments and that treatments with PGF~2α~, but not PGE~2~, led to dose-related increases in trehalose efflux from the trophocytes ([@B8]). The sugar efflux was inhibited by the COX inhibitors, indomethacin and diclofenac. A LOX inhibitor, NDGA and two PLA~2~ inhibitors, mepacrine and 4′-bromophenacyl bromide (BPB), similarly led to decreased sugar efflux from HTH-I-treated fat body. Again, the authors inferred eicosanoids act in trehalose synthesis and efflux ([@B6]).

[@B110] reported that HTH-I and --II treatments substantially increased PLA~2~ activity in membrane-enriched trophocyte preparations. The hormone effect, tested with HTH-II, was dose-dependent up to about 20 pmol/ml. Treating trophocytes with the PLA~2~ inhibitor, BPB, over the range 0 to 1,000 μM, inhibited PLA~2~ activity. The fat body PLA~2~ activity may result from a cytosolic PLA~2~ because HTH-II treatment led to translocation of the PLA~2~ activity from the cytosol to the membrane fraction. This indicates Ca^2+^ is needed for translocation to the membrane and that the PLA~2~ *per se* is Ca^2+^-independent. Their work documents PGs actions in homeostatic hormone signaling.

Eicosanoids and Insect Immunity
-------------------------------

[@B107] posed the hypothesis that eicosanoids mediate insect immune responses to bacterial infection. They tested the hypothesis in a series of simple experiments based on treating tobacco hornworms, *M. sexta*, with an inhibitor of eicosanoid biosynthesis, DEX, and ethanol for controls and separately injecting them with a red-pigmented strain of the bacterium *Serratia marcescens*. They withdrew hemolymph samples over a 60-min time course, and recovered no bacteria in hemolymph from controls and increasing numbers of bacterial colonies from the DEX-treated insects. The DEX treatments led to dose-dependent decreases in insect survival, which were reversed in insects treated with AA. In light of the short timeframes of their experiments, the authors surmised that eicosanoid metabolism mediates some or all of the early immune responses in insects. These experiments opened a new research corridor on biochemical signaling in insect immunity.

Nodule formation of hemocytes is a cellular immune response to bacterial and other microbial infection ([@B26]). [@B59] reported that PGs and LOX products mediate formation of hemocyte microaggregates and melanotic nodules following *S. marcescens* infections. Hemocytes migrate toward sites of infection and wounding, where they act in host defense. [@B58] reported that eicosanoids mediate hemocyte migration. Phagocytosis is another cellular immune response by engulfing and secondary killing of invading microbes by phagocytic cells. PGE~2~ stimulates phagocytosis in the greater wax moth, *Galleria mellonella* ([@B57]), the beet armyworm, *S. exigua* ([@B91]) and the bug *Rhodnius prolixus* ([@B31]). The secondary killing of engulfed microbes is driven by reactive oxygen species (ROS). [@B73] demonstrated that eicosanoids mediate ROS production by activating NADPH-dependent oxidase (NOX), as seen also in vertebrates. We infer that both phases of phagocytosis, the engulfment and secondary killing of bacteria are mediated by eicosanoids. Upon infection by parasitoid eggs or EPNs, insects form several hemocyte layers around the relatively large size of pathogens to prevent oxygen or nutrient supply ([@B109]). [@B14] showed that the hemocytic encapsulation is mediated by eicosanoids in *D. melanogaster* exposed to the endoparasitoid wasp, *Leptopilina boulardi*. Thus, eicosanoids are key mediators of insect cellular immunity ([@B106]; [@B44]).

Humoral immune responses in insects include quinone melanization by phenoloxidase (PO) and killing microbes by antimicrobial peptides (AMPs) ([@B51]). In the *S. exigua* model, PGE~2~ mediates release of inactive prophenoloxidase (PPO) from specific hemocytes (oenocytoids) into hemolymph by activating oenocytoid cell lysis (OCL) through a specific membrane receptor ([@B12]) that is expressed solely in oenocytoids in all life stages. Inhibiting expression of the *S. exigua* PGE~2~ receptor led to reduced OCL and PO activity ([@B92]; [@B94]). PPO is activated into PO by enzymes in hemolymph, which initiates melanization, a key step in both humoral and cellular immune responses, and also in wound-healing response ([@B11]). Indeed, a treatment of eicosanoid biosynthesis inhibitor (EBI) significantly suppressed clot formation around wounds of *Drosophila* larvae ([@B37]). EBI treatment inhibits expression of two AMP genes of *B. mori* against bacterial challenge ([@B60]). In *Drosophila*, EBI specifically inhibits expression of AMP genes in IMD signal pathway ([@B123]). In contrast, eicosanoids may mediate expression of AMP genes in both Toll/IMD pathways in the Oriental fruit fly, *Bactrocera dorsalis* ([@B52]). In the fruit fly, a PLA~2~ gene is linked with immune responses. Its RNAi treatment led to reduced gene expression of MyD88 and Relish along with suppressive expression of defensin (Toll pathway marker) and diptericin (IMD pathway marker). Similarly, both Toll/IMD signal pathways are controlled by EBI treatment in *S. exigua*, which led to significant suppression of AMP biosynthesis ([@B36]). Thus, eicosanoids also mediate humoral immune responses in insects.

Eicosanoids mediating insect immune responses exhibit functional cross-talks with other immune mediators. Upon non-self recognition, immune mediators propagate the recognition signal to nearby immune effectors, hemocytes and fat body ([@B34]). These immune mediators include cytokines (small protein molecules, 5--20 kDa) such as the insect cytokine, plasmatocyte-spreading peptide (PSP; [@B17]), biogenic monoamines, nitric oxide (NO), and eicosanoids ([@B44]). Recent reports indicate that there is substantial cross-talk among immune mediators, in which eicosanoids play a crucial role in mediating most downstream signal ([Figure 4](#F4){ref-type="fig"}).

![Cross-talk among immune mediators in insects. A cytokine, plasmatocyte-spreading peptide (PSP) binds to its receptor, methuselah 10 (Mthl10) activates a small G protein, Rac1, which is also activated by biogenic monoamines, octopamine (OA) or 5-hydroxytryptamine (5-HT). Rac1 activates PLA~2~ to produce prostaglandin (PG). PLA~2~ is also activated by a protein kinase, Pelle, which is activated by Toll receptor. The Toll pathway also induces nitric oxide synthase (NOS) or antimicrobial peptide (AMP) genes. NOS synthesizes nitric oxide (NO) and activates PLA~2~. The activated PLA~2~ is involved in PG biosynthesis. PG triggers oenocytoid cell lysis (OCL) and release PSP-binding protein (PSP-BP) and prophenoloxidase (PPO). OCL is induced by sodium-potassium-chloride cotransporter (NKCC) via protein kinase C (PKC). PSP-BP facilitates PSP degradation. PG also mediates cytoskeletal rearrangement and AMP production.](fphys-09-01927-g004){#F4}

Octopamine (OA) and serotonin (5-hydroxytryptophan: 5-HT) are biogenic monoamines that stimulate phagocytosis and nodulation in insects via the small G protein, Rac1 ([@B10]; [@B43]; [@B42]) through specific cell surface receptors ([@B27]; [@B75]). Phentolamine (an OA receptor antagonist) and ketanserin (a 5-HT receptor antagonist) suppress cellular immune responses of *S. exigua* in a competitive manner, and their inhibitory effects are reversed by an addition of AA ([@B43]). Eicosanoids are the downstream signals of the monoamines probably by increasing intracellular calcium concentrations as seen in the forest tent caterpillar moth, *Malacosoma disstria* ([@B39]) and by subsequently translocating cPLA~2~ to its substrate PLs ([@B96]). Indeed, a PLA~2~ of *T. castaneum* associated with immunity was translocated from cytosol to membrane in response to bacterial challenge ([@B95]).

The insect cytokine, PSP, is expressed as a proPSP in hemocytes and fat body ([@B17]) and cleaved into a 23 residue PSP that mediates plasmatocyte-spreading behavior in some plasmatocyte subpopulations ([@B19]). PSP is a member of the ENF peptide family which includes growth-blocking peptide (GBP) and paralytic peptides (PPs; [@B97]). PSP induces cell-spreading via an approximately 190 kDa receptor ([@B18]), identified in *Drosophila* ([@B111]) as a Methuselah-like receptor-10 (Mthl10), for GBP. PSP mediates hemocyte-spreading behavior via cross-talk with other immune mediators ([@B44]). The effects of silencing the gene encoding proPSP were reversed by PSP or AA treatments ([@B99]). The PSP-stimulated hemocyte-spreading was impaired by inhibiting eicosanoid biosynthesis. Activation of eicosanoid biosynthesis by PSP or biogenic monoamines follows receptor-driven activation of Rac1. A Rac1 gene (*SeRac1*) that acts in cytoskeleton functions ([@B42]) was identified in *S. exigua* hemocytes ([@B66]). Bacterial challenge up-regulated *SeRac1* expression (by \>37-fold) and silencing *SeRac1* inhibited PSP- or biogenic monoamine-mediated hemocyte-spreading behavior. Injection of PGE~2~ into *SeRac1*-silenced larvae rescued the influence of these immune mediators on hemocyte-spreading. PSP and biogenic amines increased PLA~2~ activity, but not in hemocytes from *SeRac1*-silenced larvae. Therefore, we inferred that Rac1 transduces PSP and biogenic monoamine signaling by activating PLA~2~ activity, which leads to eicosanoid biosynthesis. PSP and eicosanoids mediate PPO activation via eicosanoids ([@B65]). OCL is required for the release of PPO into plasma, where it is activated ([@B41]). In *S. exigua*, PO is activated by PGs, which mediate OCL to release PPO ([@B92]). PSP induces PPO activation in *S. exigua* ([@B65]), suggesting that PG acts downstream of PSP for PPO activation. Injection of PGE~2~ to the larvae treated with DEX rescued the PPO activation. [@B66] reported that Rac1 facilitates cross-talk between PSP and eicosanoids. In *S. exigua* Rac1 activates PLA~2~ for PG biosynthesis. The PPO induction period by PGE~2~ treatment was significantly reduced in Rac1-silenced larvae. This reduction of PPO activation by PSP silencing is explained by the absence of endogenous PSP to sustain PLA~2~ activation for PG biosynthesis. Thus, PSP requires PGE~2~ as a downstream mediator of PPO activation.

Cross-talk between PSP and eicosanoids acts in down-regulation of PPO activation during later infection stages ([@B65]). A specific PSP-binding protein (PSP-BP) terminates the PSP activation of PO because RNAi silencing of PSP-BP extended the PPO activation period ([@B65]). This explains how eicosanoids mediate both activation and inactivation of PPO.

NO is a small, membrane-permeable signal molecule that acts in nervous and immune systems in insects and vertebrates ([@B80]). NO is synthesized from L-arginine by NO synthase (NOS), which in mammals exists in three forms ([@B20]). NO mediates immunity in mosquitoes, defending them from malarial parasites ([@B24]; [@B55]). In *M. sexta*, RNAi suppressed *NOS* expression showed that NO is directly associated with immunity ([@B28]). Cross-talk between cytokine and NO signaling induces AMP gene expression in *B. mori*, where a PSP-like cytokine elevates NO concentration by inducing *NOS* expression ([@B38]). [@B85] showed that bacterial injection increased NO concentrations in larval hemocytes and fat body and that silencing a *S. exigua* nitric oxide synthase (*SeNOS*) gene suppressed NO concentrations. The silencing of *SeNOS* expression and, separately, injecting L-NAME (a specific NOS inhibitor) led to reduced PLA~2~ activities in hemocytes and fat body relative to controls. Injecting a NO donor, S-nitroso-N-acetyl-DL-penicillamine, increased PLA~2~ activity in a dose-dependent manner. Eicosanoids did not influence NO concentrations in immune challenged larvae, from which it can be inferred that eicosanoid signaling is downstream to NO signaling.

NO treatments alone led to AMP induction because injection of an NO analog, SNAP, without bacterial challenge induced AMP gene expression ([@B84]). There is an additional line of cross-talk between the Toll/IMD pathways and NO signaling because RNAi of Toll or IMD signal components led to reduced levels of NO by inhibiting NOS expression in *S. exigua* ([@B84]). We infer that Toll/IMD signaling triggers NO signaling, which activates PLA~2~ to synthesize eicosanoids. In addition, a recent study ([@B89]) showed that two Toll signal components (MyD88 and Pelle) activate PLA~2~ in *S. exigua*, suggesting a direct cross-talk between Toll and eicosanoid signal pathways.

Prospectus
==========

Prostaglandins and other eicosanoids make up a fundamental signaling system in insect biology. We described their actions at the whole animal, cellular and molecular levels of biological organization. These points mark valuable new knowledge on insect biology. So far, the idea that eicosanoids mediate cellular immune reactions has been confirmed in 29 or so insect species from seven orders ([@B104]). Broader testing is necessary to develop the general principle that eicosanoids mediate insect immune functions. Similarly, intracellular cross-talk among immune signal moieties has been investigated in one lepidopteran species, *S. exigua*, which opens questions and hypotheses on the mechanisms of PG actions in insects generally. The overall picture is a broad outline of eicosanoid actions, each of which is an open field of meaningful research.

The eicosanoid signaling system may be a valuable target in applied entomology. [@B69] first recognized the pathogenic mechanisms of bacteria in the genera *Photorhabdus* and *Xenorhabdus*, target insect immune reactions by blocking PLA~2~s in their insect hosts. Similarly, *T. rangeli* protects itself from immune actions of its host, *R. prolixus* ([@B31]). We infer that host PLA~2~s are such potent targets that at least two bacterial genera and a eukaryotic parasite in the phylum Euglenozoa evolved mechanisms to down-regulate host immunity by blocking eicosanoid signaling via PLA~2~s. We identified several genes that were silenced to inhibit insect immunity. We put these genes forward as potential targets that can lead to functional limitations in pest insect immune reactions to microbial and/or parasitic invasions. On the idea that virtually all pest insects become infected during their life cycles in crop plants ([@B116]), targeted inhibition of insect immunity has potential for development into a novel insect management technology.
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